iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Sold by Kraft Davis & Associates LLC

Kraft Davis & Associates LLC trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 11.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,209 shares of the company’s stock after selling 3,513 shares during the quarter. Kraft Davis & Associates LLC owned approximately 0.28% of iShares U.S. Pharmaceuticals ETF worth $1,955,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP boosted its holdings in iShares U.S. Pharmaceuticals ETF by 9.4% in the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after buying an additional 159 shares during the last quarter. Assetmark Inc. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after acquiring an additional 216 shares in the last quarter. US Bancorp DE boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after acquiring an additional 222 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its position in shares of iShares U.S. Pharmaceuticals ETF by 7.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock worth $254,000 after purchasing an additional 266 shares in the last quarter. Finally, Cultivar Capital Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at $25,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $66.69 on Wednesday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $57.62 and a fifty-two week high of $72.94. The firm has a market capitalization of $673.57 million, a P/E ratio of 6.49 and a beta of 0.58. The stock’s fifty day moving average is $70.24 and its two-hundred day moving average is $68.72.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.